Implementation of radiation segmentectomy for early-stage hepatocellular carcinoma

Robert J. Lewandowski; Riad Salem

doi:10.1016/S2468-1253(22)00161-3

Implementation of radiation segmentectomy for early-stage hepatocellular carcinoma

Robert J. Lewandowski, Riad Salem

Radiology

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	783-784
Number of pages	2
Journal	The Lancet Gastroenterology and Hepatology
Volume	7
Issue number	9
DOIs	https://doi.org/10.1016/S2468-1253(22)00161-3
State	Published - Sep 2022

Funding

RJL has received consulting fees from Boston Scientific, Bard, Varian, ABK Medical, Alhambra Medical, and AstraZeneca; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Boston Scientific; an NIH grant, paid to his institution (NIH R01 CA 233787); and membership of the Executive Council Society of Interventional Radiology. RS has received consulting fees from Boston Scientific, Sirtex, Cook, Bard, Eisai, Genentech, and AstraZeneca.

ASJC Scopus subject areas

Hepatology
Gastroenterology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2468-1253(22)00161-3

Cite this

@article{8c2ae728cece428bbd658ea7944f839a,

title = "Implementation of radiation segmentectomy for early-stage hepatocellular carcinoma",

author = "Lewandowski, {Robert J.} and Riad Salem",

note = "Funding Information: RJL has received consulting fees from Boston Scientific, Bard, Varian, ABK Medical, Alhambra Medical, and AstraZeneca; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Boston Scientific; an NIH grant, paid to his institution (NIH R01 CA 233787); and membership of the Executive Council Society of Interventional Radiology. RS has received consulting fees from Boston Scientific, Sirtex, Cook, Bard, Eisai, Genentech, and AstraZeneca.",

year = "2022",

month = sep,

doi = "10.1016/S2468-1253(22)00161-3",

language = "English (US)",

volume = "7",

pages = "783--784",

journal = "The Lancet Gastroenterology and Hepatology",

issn = "2468-1253",

publisher = "Elsevier Ltd",

number = "9",

}

TY - JOUR

T1 - Implementation of radiation segmentectomy for early-stage hepatocellular carcinoma

AU - Lewandowski, Robert J.

AU - Salem, Riad

N1 - Funding Information: RJL has received consulting fees from Boston Scientific, Bard, Varian, ABK Medical, Alhambra Medical, and AstraZeneca; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Boston Scientific; an NIH grant, paid to his institution (NIH R01 CA 233787); and membership of the Executive Council Society of Interventional Radiology. RS has received consulting fees from Boston Scientific, Sirtex, Cook, Bard, Eisai, Genentech, and AstraZeneca.

PY - 2022/9

Y1 - 2022/9

UR - http://www.scopus.com/inward/record.url?scp=85135389091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85135389091&partnerID=8YFLogxK

U2 - 10.1016/S2468-1253(22)00161-3

DO - 10.1016/S2468-1253(22)00161-3

M3 - Comment/debate

C2 - 35617979

AN - SCOPUS:85135389091

SN - 2468-1253

VL - 7

SP - 783

EP - 784

JO - The Lancet Gastroenterology and Hepatology

JF - The Lancet Gastroenterology and Hepatology

IS - 9

ER -

Implementation of radiation segmentectomy for early-stage hepatocellular carcinoma

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this